Page results
-
UCLH provides an audiological service for GPs who would like to refer patients for age related audiological assessments.
-
Our vascular service has a major emphasis on endovascular (minimally invasive) treatments for vascular diseases, and this approach has largely replaced conventional open vascular surgery at UCLH.
-
This patient information is about obstructed hemi-vaginas.
-
This patient information will describe what having a transverse vaginal septum means, how it can affect you, and what are the treatment options.
-
This patient information will describe what having a transverse vaginal septum means, how it can affect you, and what are the treatment options.
-
Brooke Robinson tells us what it is like to work to in neuroradiography at the National Hospital for Neurology and Neurosurgery.
-
The cochlear implant programme was founded in 1982, and we were the first clinical cochlear implant programme in the UK. The team has been involved with the successful implantation of more than 2,000 patients, both adults and children, from all over the UK.
-
Over half a million non-sterile blue gloves have been saved from landfill since we launched our Gloves Off initiative in May last year.
-
Information about the autogenic training service at the Royal London Hospital for Integrated Medicine.
-
Info about our regular, online origami club for people under the care of UCLH for cancer or a blood condition
File results
-
FOI/2024/0518 - Post partum balloons buying/ usage numbers
-
FOI/2024/0520 - Treatment of melanoma
-
FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer
-
FOI/2024/0527 - Treatment for renal cell carcinoma
-
FOI/2024/0528 - Open MRIs referrals for patient size/ spend on specialist bariatric equipment 2017-2024
-
FOI/2024/0529 - Medical Associate Professionals (MAPs) at Trust
-
FOI/2024/0530 - Radiology/ imaging examinations/ patient access to radiology images
-
FOI/2024/0532 - Patient treatment/ care/ consent
-
FOI/2024/0543 - Guidelines, policies for the treatment of obesity/ pathways for Tier 3 or Tier 4 weight management services
-
FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer